Study showed oxaliplatin improved colon cancer patient survival
Friday, January 20, 2012 - 18:00
in Health & Medicine
Stage III colon cancer patients in the general population who receive adjuvant treatment for the disease have an improved rate of survival when oxaliplatin is added to 5-fluorouracil (5FU), according to a study published Jan. 20 in the Journal of the National Cancer Institute.